In silico identification of putative druggable pockets in PRL3, a significant oncology target

Grace M. Bennett
, Julia Starczewski
, Mark Vincent C. dela Cerna

Biochemistry, Chemistry & Physics

Georgia Southern University

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

3 Citations
1 Article

1 results

2021
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
Rivas, D. R., Dela Cerna, M. V. C., Smith, C. N., Sampathi, S., Patty, B. G., Lee, D. & Blackburn, J. S., Dec 2021, In: Scientific Reports. 11, 1, 10302.
Research output: Contribution to journal › Article › peer-review

Open Access
13 Scopus citations